The chemical substance with the name "methyl(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate" and CAS number "1365970-47-3" is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups and stereocenters. This substance features a tert-butyl group, which contributes to its hydrophobic properties, and difluoro substituents that may enhance its reactivity and biological activity. The presence of dioxo and aza groups suggests potential applications in medicinal chemistry, possibly as a pharmaceutical agent. The compound's cyclic and polycyclic nature indicates a rigid structure, which can influence its interaction with biological targets. Additionally, the carboxylate group may play a role in solubility and reactivity. Overall, this compound's unique structural features suggest it may exhibit interesting chemical behavior and potential therapeutic applications, warranting further investigation in the fields of organic and medicinal chemistry.

methyl(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate

1365970-47-3: The chemical substance with the name "methyl(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate" and CAS number "1365970-47-3" is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups and stereocenters. This substance features a tert-butyl group, which contributes to its hydrophobic properties, and difluoro substituents that may enhance its reactivity and biological activity. The presence of dioxo and aza groups suggests potential applications in medicinal chemistry, possibly as a pharmaceutical agent. The compound's cyclic and polycyclic nature indicates a rigid structure, which can influence its interaction with biological targets. Additionally, the carboxylate group may play a role in solubility and reactivity. Overall, this compound's unique structural features suggest it may exhibit interesting chemical behavior and potential therapeutic applications, warranting further investigation in the fields of organic and medicinal chemistry.

methyl (33R,35S,91R,92R,5S)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate

CAS 1365970-47-3

methyl(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate

methyl (33R,35S,91R,92R,5S)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate

Ref: TR-D461725